EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Minicells derived from Escherichia coli Nissle 1917 for efficient phenylalanine degradation

Xiaoya Tian iD, Kanghui Ju, Jun Zeng, Xiaona Pang, Jingyu Chen iD

Applied and Environmental Microbiology · 19.08.2026 · 92 (8)

DOI: 10.1128/aem.00944-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied and Environmental Microbiology, erschienen am 19.08.2026. Verfasst von Xiaoya Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Food Bioengineering (China National Light Industry), College of Food Science and Nutritional Engineering, China Agricultural Univer…. Hauptthemen laut MEDLINE: Phenylalanine, Escherichia coli, Metabolic Engineering. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Shandong Province, China, Provincial and Municipal Agricultural Subsidy Special Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylketonuria is an inherited metabolic disorder characterized by impaired phenylalanine (Phe) catabolism and toxic Phe accumulation. Current therapies are limited by poor long-term adherence, high cost, and biosafety concerns associated with existing or emerging approaches. Here, a non-replicative yet metabolically active platform was developed using anucleate minicells derived from Escherichia coli Nissle 1917 (EcN). A dual phenylalanine degradation system was introduced to engineer these minicells into synthetic microreactors, designated PCB101. In vitro , PCB101 degraded 10 mM Phe within 1.5 h. In a murine hyperphenylalaninemia model, intravenous injection of PCB101 (10 9 cells/mL) reduced plasma Phe by 87.5%, and oral administration (10 10 cells/mL) achieved a 66% reduction in a dose-dependent manner. These results demonstrate that EcN-derived minicells provide a controllable and biosafe chassis for efficient Phe degradation both in vitro and in vivo , supporting their potential applicability in biotherapeutic strategies requiring stable dosing and prevention of microbial proliferation. IMPORTANCE Engineered microbial systems are widely applied to perform defined metabolic functions, yet most designs rely on viable and replicating cells, intrinsically coupling functional output to population expansion. This growth-dependent paradigm complicates dose stability and raises biosafety concerns in practical applications. This study demonstrates that anucleate minicells derived from Escherichia coli Nissle 1917 retain translational and metabolic activity despite lacking chromosomal DNA and replicative capacity. By incorporating a dual phenylalanine degradation pathway, the engineered minicells efficiently reduced phenylalanine both in vitro and in vivo. This study illustrates that metabolic function can be preserved independently of cell division, providing a controllable microbial platform for applications requiring stable functional output without population expansion. This work expands the conceptual framework for non-replicative microbial systems in applied microbiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylalanineEscherichia coliMetabolic EngineeringAnimalsMice

Stichwörter der Autor:innen

Escherichia coli Nissle 1917metabolic engineeringminicellsphenylalanine degradation

Substanzen

Phenylalanine

Autor:innen und Institutionen

  • Key Laboratory of Food Bioengineering (China National Light Industry), College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
  • China Agricultural University-Sichuan Advanced Agricultural & Industrial Institute, Chengdu, China.
  • Xinjiang Laboratory of Special Environmental Microbiology, Institute of Microbiology, Xinjiang Academy of Agricultural Sciences, Urumqi, China.
  • Laboratory of Food Quality and Safety, Beijing Key Laboratory of Agricultural Product Detection and Control of Spoilage Organisms and Pesticide Residue, College of Food Science and Engineering, Beijing University of Agr…

ORCID-Profile: Xiaoya Tian, Jingyu Chen

Förderung

  • Key R&D Program of Shandong Province, China
  • Provincial and Municipal Agricultural Subsidy Special Funds

Zitieren

APA

Tian, X., Ju, K., Zeng, J., Pang, X., & Chen, J. (2026). Minicells derived from Escherichia coli Nissle 1917 for efficient phenylalanine degradation. Applied and Environmental Microbiology, 92(8). https://doi.org/10.1128/aem.00944-26

Vancouver

Tian X, Ju K, Zeng J, Pang X, Chen J. Minicells derived from Escherichia coli Nissle 1917 for efficient phenylalanine degradation. Applied and Environmental Microbiology. 2026;92(8). doi:10.1128/aem.00944-26

BibTeX
@article{Tian2026,
  author = {Tian, Xiaoya and Ju, Kanghui and Zeng, Jun and Pang, Xiaona and Chen, Jingyu},
  title = {Minicells derived from Escherichia coli Nissle 1917 for efficient phenylalanine degradation},
  journal = {Applied and Environmental Microbiology},
  year = {2026},
  volume = {92},
  number = {8},
  doi = {10.1128/aem.00944-26}
}
Kostenlos starten →